A Guide to ASPR IBx Funding: Application Process, Financial and Technical Requirements The Assistant Secretary for Preparedness and Response (ASPR) Industrial Base Expansion (IBx) team is a group within the U.S. Department of Health and Human Services that provides funding opportunities aimed at strengthening public health and medical supply chains and addressing concerns regarding domestic […]
A Guide to ASPR IBx Funding Read More »
New Request for Information (RFI) Released by the Advanced Research Projects Agency for Health (ARPA-H) Solicits Ideas for Engaging with the FDA on Regulatory Strategies for Health Innovations ARPA-H, or the Advanced Research Projects Agency for Health, is a new agency within the National Institutes of Health (NIH) that aims to accelerate the development of
New Request for Information by ARPA-H for FDA Read More »
EverGlade Consulting Funding Alert: Biden Administration Announces Launch of Successor Program to Operation Warp Speed Accompanied by the Release of New Funding Opportunities for the Development of Vaccines and Therapeutics Project Next Gen Project Next Gen is a new program launched by the Biden administration aimed at accelerating the development of new coronavirus vaccines and
Release of New Funding Opportunities for the Development of Vaccines and Therapeutics Read More »
The National Institute of Allergy and Infectious Diseases (“NIAID”) recently published Broad Agency Announcement (‘BAA”) No. HHS-NIH-NIAID-BAA2023-1, which provides funding opportunities for the advancement of promising candidate vaccines, therapeutics, and diagnostics for Biodefense, Emerging Infectious Diseases, and Pandemic Preparedness. Four Areas for NIAID Funding 1. Research Area 001 – Development of Vaccine Candidates for Biodefense
It seems that there may be a new Valley of Death on the horizon of COVID therapeutic development. Earlier this month (9 JUL) NIAID posted a Funding Opportunities Announcement soliciting proposals related to COVID therapeutic development through their Antiviral Drug Discovery (AViDD) Centers for Pathogens of Pandemic Concern program (RFA-AI-21-050: Antiviral Drug Discovery (AViDD) Centers
A New Valley of Death? by Eric Jia-Sobota Read More »
Earlier this month the Army Contracting Command published an amendment to solicitation W911QY-20-S-C001 related to Area of Interest 5, oral antiviral therapeutics. This is a procurement solicitation and specifically the USG is looking for direct-acting antivirals for COVID-19 high-risk patients. Successful offerors will be able to deliver 500,000 treatment courses of the anti-viral within eight
COVID-19 Antiviral Therapeutics Procurement by Eric Jia-Sobota Read More »
For the past 18 months companies have been confused and frustrated by the shifting USG policies regarding the development of therapeutics as part of the COVID-19 response. BARDA was back and forth as parts of the BAA were suspended, unsuspended, and resuspended. The American rescue Plan legislation was passed about six months ago and although
New Opportunity for COVID Therapeutics by Eric Jia-Sobota Read More »
The Joint Army Contracting Command and the Joint COVID Response Division (ACC-JCRD) recently published a solicitation seeking Commercial Solutions to decrease US reliance on fragile global supply chains and increase preparedness for future pandemics. The solicitation seeks to establish, expand, and accelerate the availability of domestically-produced supplies in several different areas, some of which may
ACC-JCRD seeking Commercial Solutions by Eric Jia-Sobota Read More »
Executive Summary BARDA’s suspension of funding for COVID-19 therapeutics risks repeating mistakes of past pandemics as it may cause industry to pull out of the development space, experts say. Industry sources are concerned the Biden administration is focusing on funding NIH at the expense of BARDA. The Biomedical Advanced Research and Development Authority quietly suspended
BARDA Funding Freeze Risks Companies Abandoning COVID Therapeutic Work Read More »
The DPA Title III program just received an additional $10B in the recovery legislation that was recently passed. The DPA program is administered by the US Air Force and more information can be found here beta.SAM.gov. The solicitation is open until JUL 2024 to offerors that meet the requirements of the Defense Production Act of
DPA Funding Opportunity by Eric Jia-Sobota Read More »
Recently we became aware of two new opportunities for federal funding through HHS and DoD. We believe these may present exciting new avenues for companies that work in these areas. First, BARDA just posted two new RFIs with a response deadline of April 23, 2021. Links to these are here: beta.SAM.gov | Search – Expansion
New BARDA RFIs Released by Eric Jia-Sobota Read More »
Recently, the Coalition for Epidemic Preparedness Innovations (CEPI) published a call for proposals that is open from 28 JAN 2021 to 28 MAY 2021 and can be found here [CEPICfPCallText.pdf]. Trials that expand access in low and middle income countries is strongly encouraged. The objective is to expand access to vaccines that are already in
CEPI Funding Opportunity by Eric Jia-Sobota Read More »
